Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma

被引:71
|
作者
Landwehr, Laura-Sophie [1 ]
Altieri, Barbara [1 ]
Schreiner, Jochen [1 ]
Sbiera, Iuliu [1 ]
Weigand, Isabel [1 ]
Kroiss, Matthias [1 ,2 ]
Fassnacht, Martin [1 ,2 ,3 ]
Sbiera, Silviu [1 ,2 ]
机构
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Div Endocrinol & Diabet, Wurzburg, Germany
[2] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Clin Chem & Lab Med, Wurzburg, Germany
关键词
immunity; immunotherapy; lymphocytes; tumor-infiltrating; t-lymphocytes; tumor microenvironment; REGULATORY T-CELLS; EUROPEAN-SOCIETY; PHASE-II; CANCER; COLLABORATION; PEMBROLIZUMAB; MANAGEMENT; NIVOLUMAB; SURVIVAL; EFFICACY;
D O I
10.1136/jitc-2019-000469
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in similar to 60% of patients and associated with particularly poor prognosis. Results of first clinical trials using immune checkpoint inhibitors were heterogeneous. Here we characterize tumor-infiltrating T lymphocytes (TILs) in ACC in association with glucocorticoids as potential explanation for resistance to immunotherapy. Methods We performed immunofluorescence analysis to visualize tumor-infiltrating T cells (CD3(+)), T helper cells (CD3(+)CD4(+)), cytotoxic T cells (CD3(+)CD8(+)) and regulatory T cells (Tregs; CD3(+)CD4(+)FoxP3(+)) in 146 ACC tissue specimens (107 primary tumors, 16 local recurrences, 23 metastases). Quantitative data of immune cell infiltration were correlated with clinical data (including glucocorticoid excess). Results 86.3% of ACC specimens showed tumor infiltrating T cells (7.7 cells/high power field (HPF)), including T helper (74.0%, 6.7 cells/HPF), cytotoxic T cells (84.3%, 5.7 cells/HPF) and Tregs (49.3%, 0.8 cells/HPF). The number of TILs was associated with better overall survival (HR for death: 0.47, 95% CI 0.25 to 0.87), which was true for CD4(+)- and CD8(+) subpopulations as well. In localized, non-metastatic ACC, the favorable impact of TILs on overall and recurrence-free survival was manifested even independently of ENSAT (European Network for the Study of Adrenal Tumors) stage, resection status and Ki67 index. T helper cells were negatively correlated with glucocorticoid excess (Phi=-0.290, p=0.009). Patients with glucocorticoid excess and low TILs had a particularly poor overall survival (27 vs. 121 months in patients with TILs without glucocorticoid excess). Conclusion Glucocorticoid excess is associated with T cell depletion and unfavorable prognosis. To reactivate the immune system in ACC by checkpoint inhibitors, an inhibition of adrenal steroidogenesis might be pivotal and should be tested in prospective studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Clonal dynamics of tumor-infiltrating lymphocytes
    Yu, R
    Fujio, K
    Tahara, H
    Araki, Y
    Yamamoto, K
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (06) : 1754 - 1763
  • [42] Tumor-infiltrating lymphocytes in the immunotherapy era
    Sterre T. Paijens
    Annegé Vledder
    Marco de Bruyn
    Hans W. Nijman
    Cellular & Molecular Immunology, 2021, 18 : 842 - 859
  • [43] The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
    Dong Liu
    Lara Rosaline Heij
    Zoltan Czigany
    Edgar Dahl
    Sven Arke Lang
    Tom Florian Ulmer
    Tom Luedde
    Ulf Peter Neumann
    Jan Bednarsch
    Journal of Experimental & Clinical Cancer Research, 41
  • [44] Tumor-infiltrating lymphocytes A new hope
    Sarnaik, Amod A.
    Hwu, Patrick
    Mule, James J.
    Pilon-Thomas, Shari
    CANCER CELL, 2024, 42 (08)
  • [45] The tumor-infiltrating lymphocytes of intrahepatic cholangiocarcinoma
    Okubo, Saki
    Fuji, Hiroaki
    Tsushima, Hiraki
    Iwaisako, Keiko
    CANCER SCIENCE, 2022, 113 : 561 - 561
  • [46] Tumor-infiltrating lymphocytes in the immunotherapy era
    Paijens, Sterre T.
    Vledder, Annege
    de Bruyn, Marco
    Nijman, Hans W.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (04) : 842 - 859
  • [47] CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
    Fukunaga, A
    Miyamoto, M
    Cho, Y
    Murakami, S
    Kawarada, Y
    Oshikiri, T
    Kato, K
    Kurokawa, T
    Suzuoki, M
    Nakakubo, Y
    Hiraoka, K
    Itoh, T
    Morikawa, T
    Okushiba, S
    Kondo, S
    Katoh, H
    PANCREAS, 2004, 28 (01) : E26 - E31
  • [48] Phenotypic analysis of tumor-infiltrating lymphocytes in human hepatocellular carcinoma.
    Chen, CH
    Lee, HS
    Huang, GT
    Yang, PM
    Yu, WY
    Chen, DS
    Sheu, JC
    HEPATOLOGY, 2001, 34 (04) : 176A - 176A
  • [49] The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study
    El-Rebey, Hala S.
    Abdou, Asmaa G.
    Sultan, Mervat M.
    Ibrahim, Shymaa H.
    Holah, Nanis S.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (03) : 188 - 200
  • [50] Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
    Wongpattaraworakul, Wattawan
    Choi, Allen
    Buchakjian, Marisa R.
    Lanzel, Emily A.
    Rajan, K. D. Anand
    Simons, Andrean L.
    BMC CANCER, 2024, 24 (01)